{
    "clinical_study": {
        "@rank": "41764", 
        "arm_group": {
            "arm_group_label": "Study Oral Nutritional Supplement", 
            "arm_group_type": "Experimental", 
            "description": "2 containers a day of a high calorie, complete, balanced, ready-to-drink oral nutritional supplement with a new protein blend."
        }, 
        "brief_summary": {
            "textblock": "The objective of this study is to evaluate gastrointestinal tolerance of an oral nutritional\n      supplement containing a new protein blend in healthy elderly subjects."
        }, 
        "brief_title": "Evaluation of an Oral Nutritional Supplement", 
        "completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "condition": "Gastro-intestinal Tolerance", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Subjects will be eligible for the study if they meet all of the following inclusion\n        criteria:\n\n          1. Age \u2265 60 and \u2264 90 years\n\n          2. Body Mass Index (BMI) > 20 but < 35\n\n        Exclusion Criteria:\n\n        Subjects will be excluded from the study if they meet any of the following criteria:\n\n          1. History of diabetes\n\n          2. Currently taking or has taken antibiotic within 1 week prior to enrollment\n\n          3. Major surgery less than 3 months prior to enrollment in the study\n\n          4. Current active malignant disease or was treated within the last 6 months for cancer\n\n          5. Immunodeficiency disorder\n\n          6. Myocardial infarction within the last 3 months prior to enrollment\n\n          7. Chronic obstructive pulmonary disease (COPD)\n\n          8. Allergy to any of the ingredients in the study product\n\n          9. Aversion to flavor of product being tested\n\n         10. Obstruction of the gastrointestinal tract precluding ingestion or absorption of the\n             study product, inflammatory bowel disease, ulcer, gastric reflux disease, short bowel\n             syndrome, or other major gastrointestinal disease\n\n         11. Dementia, brain metastases, eating disorders, history of significant neurological or\n             psychiatric disorder\n\n         12. Pursuing or has unintentional weight loss or weight gain \u2265 5% in last 4 weeks\n\n         13. Medications/dietary supplements/substances that could profoundly modulate metabolism\n             or affect GI motility"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "90 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01781624", 
            "org_study_id": "BL13"
        }, 
        "intervention": {
            "arm_group_label": "Study Oral Nutritional Supplement", 
            "description": "Supplement contains a new protein mix consisting of a blend of milk, soy, and pea protein.", 
            "intervention_name": "Study Oral Nutritional Supplement", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 31, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45249"
                }, 
                "name": "Radiant Research, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of an Oral Nutritional Supplement With a New Protein Blend", 
        "overall_official": {
            "affiliation": "Abbott Nutrition", 
            "last_name": "Jeffrey Nelson, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Self-reported questionnaire", 
            "measure": "Gastro-Intestinal Tolerance", 
            "safety_issue": "No", 
            "time_frame": "Study Day 1-7"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01781624"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Self-reported number of containers consumed per day", 
                "measure": "Study Product Compliance", 
                "safety_issue": "No", 
                "time_frame": "Study Day 1-7"
            }, 
            {
                "measure": "Weight", 
                "safety_issue": "No", 
                "time_frame": "Study Day 1 and 8"
            }
        ], 
        "source": "Abbott Nutrition", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Abbott Nutrition", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}